←Back to Expert Scholars
Translational Medicine / 转化医学Antibody Engineering, Bispecific Design
Paul Carter
PhD
🏢Genentech🌐USA
Senior Principal Scientist
95
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Paul Carter pioneered antibody humanization and the knob-into-hole bispecific antibody architecture at Genentech, enabling multiple FDA-approved oncology bispecifics. He has shaped modern antibody engineering for cancer for over three decades.
Share:
🧪Research Fields 研究领域
knob-into-hole bispecific
antibody engineering
trastuzumab humanization
Fc engineering
bispecific format
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Paul Carter 的研究动态
Follow Paul Carter's research updates
留下邮箱，当我们发布与 Paul Carter（Genentech）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment